Back to search
Peginterferon alfa-2A (40 KD) (PEGASYS) in combination with ribavirin (RBV): efficacy and safety results from a phase III, randomized, double-blind, multicentre study examining effect of duration of treatment and RBV dose
Data up to Jan 2025
Published2002
Citations143
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
No citing papers found in database